Literature DB >> 1528354

Effects of p-chloroamphetamine on brain serotonin neurons.

R W Fuller1.   

Abstract

p-Chloroamphetamine (PCA) is a useful pharmacologic tool for selectively increasing brain serotonin function acutely by release of serotonin into the synaptic cleft. PCA produces behavioral, neurochemical and neuroendocrine effects believed due to serotonin release after doses in the range of 0.5-5 mg/kg. At higher doses and at longer times, PCA causes depletion of brain serotonin. The mechanisms of this depletion are not well understood but require the serotonin uptake carrier. Antagonism of PCA-induced depletion of brain serotonin is a useful means of assessing the ability of a compound to block the serotonin uptake carrier on brain serotonin neurons. PCA can also be used as a neurotoxic agent to deplete brain serotonin in functional studies, apparently by destroying some serotonergic nerve terminals. Used in this way, PCA has an advantage over 5,6- and 5,7-dihydroxytryptamines in being effective by systemic injection, and it affects brain serotonergic projections with a different neuroanatomic specificity than the dihydroxytryptamines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528354     DOI: 10.1007/bf00969891

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  71 in total

1.  Psychopharmacological studies of some 1-(chlorophenyl)-2-aminopropanes. I. Effects on apetive-controlled behavior.

Authors:  J E OWEN
Journal:  J Pharm Sci       Date:  1963-07       Impact factor: 3.534

2.  Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.

Authors:  T Nabeshima; K Yamaguchi; K Ishikawa; H Furukawa; T Kameyama
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

3.  Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.

Authors:  R A Gazzara; H Takeda; A K Cho; S G Howard
Journal:  Eur J Pharmacol       Date:  1989-09-13       Impact factor: 4.432

4.  Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.

Authors:  D R Thomas; D R Nelson; A M Johnson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Comparison of the oxime and the hydroxylamine derivatives of 4-chloroamphetamine as depletors of brain 5-hydroxyindoles.

Authors:  R W Fuller; K W Perry; J C Baker; C J Parli; N Lee; W A Day; B B Molloy
Journal:  Biochem Pharmacol       Date:  1974-12-01       Impact factor: 5.858

6.  Neurochemical effects of serotonin neurotoxins: an introduction.

Authors:  R W Fuller
Journal:  Ann N Y Acad Sci       Date:  1978-06-12       Impact factor: 5.691

7.  Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour.

Authors:  P H Hutson; G Curzon
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

8.  Unlike systemic administration of p-chloroamphetamine, direct intracerebral injection does not produce degeneration of 5-HT axons.

Authors:  U V Berger; M E Molliver; R Grzanna
Journal:  Exp Neurol       Date:  1990-09       Impact factor: 5.330

9.  Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms.

Authors:  E Sanders-Bush; J A Bushing; F Sulser
Journal:  J Pharmacol Exp Ther       Date:  1975-01       Impact factor: 4.030

10.  A frequency analysis of behavior components of the serotonin syndrome produced by p-chloroamphetamine.

Authors:  C L Kutscher; B K Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  1979-12       Impact factor: 3.533

View more
  11 in total

1.  In vivo [¹⁸F] FDG PET imaging reveals that p-chloroamphetamine neurotoxicity is associated with long-term cortical and hippocampal hypometabolism.

Authors:  Luis García-García; Mercedes Delgado; Ahmed Anis Al-Sayed; Pablo Bascuñana; Rubén Fernández de la Rosa; Paloma Bermejo-Bescós; Sagrario Martín-Aragón; Miguel A Pozo
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

2.  Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go/no-go task in rats.

Authors:  Daiki Masaki; Chihiro Yokoyama; Seijiro Kinoshita; Hideto Tsuchida; Yasuhito Nakatomi; Kanji Yoshimoto; Kenji Fukui
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

3.  Regrowth of Serotonin Axons in the Adult Mouse Brain Following Injury.

Authors:  Yunju Jin; Sarah E Dougherty; Kevin Wood; Landy Sun; Robert H Cudmore; Aya Abdalla; Geetha Kannan; Mikhail Pletnikov; Parastoo Hashemi; David J Linden
Journal:  Neuron       Date:  2016-08-04       Impact factor: 17.173

Review 4.  Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.

Authors:  G Huether; D Zhou; E Rüther
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 5.  Neuronal Redevelopment and the Regeneration of Neuromodulatory Axons in the Adult Mammalian Central Nervous System.

Authors:  Patrick Cooke; Haley Janowitz; Sarah E Dougherty
Journal:  Front Cell Neurosci       Date:  2022-04-22       Impact factor: 6.147

6.  Altered postsynaptic-density-levels of caldendrin in the para-chloroamphetamine-induced serotonin syndrome but not in the rat ketamine model of psychosis.

Authors:  Karl-Heinz Smalla; Jale Sahin; Jörg Putzke; Wolfgang Tischmeyer; Eckart D Gundelfinger; Michael R Kreutz
Journal:  Neurochem Res       Date:  2009-02-18       Impact factor: 3.996

7.  Depletion of serotonin decreases the effects of the kappa-opioid receptor agonist U-69593 on cocaine-stimulated activity.

Authors:  Elena Zakharova; Stephanie L Collins; Maria Aberg; Adarsh Kumar; J B Fernandez; Sari Izenwasser
Journal:  Eur J Pharmacol       Date:  2008-02-29       Impact factor: 4.432

8.  Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography-chemical ionization-tandem mass spectrometry.

Authors:  Shoko Negishi; Yukiko Nakazono; Yuko T Iwata; Tatsuyuki Kanamori; Kenji Tsujikawa; Kenji Kuwayama; Tadashi Yamamuro; Kazuna Miyamoto; Takuya Yamashita; Fumiyo Kasuya; Hiroyuki Inoue
Journal:  Forensic Toxicol       Date:  2015-05-19       Impact factor: 4.096

9.  Para-Halogenation of Amphetamine and Methcathinone Increases the Mitochondrial Toxicity in Undifferentiated and Differentiated SH-SY5Y Cells.

Authors:  Xun Zhou; Jamal Bouitbir; Matthias E Liechti; Stephan Krähenbühl; Riccardo V Mancuso
Journal:  Int J Mol Sci       Date:  2020-04-18       Impact factor: 5.923

Review 10.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.